For over a century, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Merck is a leading global biopharmaceutical company with a diversified portfolio of prescription medicines, vaccines, biologic therapies, including biosimilars, and animal health products. In Canada, Merck is a leader in a broad range of areas such as oncology, infectious diseases, diabetes, and vaccines, and markets more than 250 pharmaceutical and animal health products.
Based in Montréal, Québec, Merck employs approximately 810 people across Canada. Merck is one of the top R&D investors in Canada, with investments totalling $35.2 million in 2016 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada.